Actinium Pharmaceuticals presented three abstracts at the 68th ASH Annual Meeting highlighting clinical advances with Iomab-ACT, a targeted CD45 radioimmunotherapy. The studies demonstrate Iomab-ACT's potential as a safer conditioning agent before CAR T-cell therapy and allogeneic stem cell transplantation, including in severe sickle cell disease. This approach aims to reduce reliance on conventional chemotherapy by using targeted radiation to prepare patients for cellular and gene therapies. The company plans further development to establish Iomab-ACT as a universal conditioning regimen for these treatments.
Actinium Pharmaceuticals' clinical updates on Iomab-ACT provide context for readers interested in health-sector developments. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 04, 2026 20:41 WIB: out of 150 priced US health-sector stocks tradable on Pluang, 127 rose and 19 fell today. Notable movers include TLRY at USD 2.78 with a 1-day change of +4.91% and Pluang order activity of 96% Sell / 4% Buy, ALC at USD 75.51 with a 1-day change of +4.34% and Pluang order activity of 91% Sell / 9% Buy, and SYRE at USD 95.00 with a 1-day change of -4.30%.
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
